Majalah Anestesia & Critical Care (MACC)
Vol 44 No 3 (2026): Oktober

Peak Thromboinflammatory Biomarkers and ICU Mortality in Severe Viral Pneumonia

I Made Prema Putra (Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Udayana - Udayana University Hospital, Denpasar, Indonesia)
Made Wirga Wirgunatha (Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Udayana - Udayana University Hospital, Denpasar, Indonesia)
Putu Ugi Sugandha (Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Udayana - Udayana University Hospital, Denpasar, Indonesia)
I Made Harry Pranata (Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Udayana - Udayana University Hospital, Denpasar, Indonesia)
Putu Eka Nantha Kusuma (Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Udayana - Udayana University Hospital, Denpasar, Indonesia)
I Gusti Ngurah Mahaalit Aribawa (Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Udayana - Udayana University Hospital, Denpasar, Indonesia)
I Gusti Agung Gede Utara Hartawan (Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Udayana - Udayana University Hospital, Denpasar, Indonesia)
Putu Agus Surya Panji (Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Udayana - Udayana University Hospital, Denpasar, Indonesia)
Made Wiryana (Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Udayana - Udayana University Hospital, Denpasar, Indonesia)



Article Info

Publish Date
31 Oct 2026

Abstract

Introduction: Risk stratification in severe viral pneumonia requiring intensive care may benefit from integrating clinical variables and thromboinflammatory biomarkers. This study aim to evaluated the association of peak D-dimer, C-reactive protein (CRP), fibrinogen, and interleukin-6 (IL-6) with ICU mortality. Methods: This retrospective cohort study used secondary data from confirmed SARS-CoV-2-related severe viral pneumonia patients admitted to the ICU from July to August 2021. Peak biomarker values during ICU care were analyzed with baseline clinical covariates. The primary outcome was ICU mortality. Bivariable testing, logistic regression using log-transformed biomarkers, and receiver operating characteristic analysis were performed. Results: Forty-one patients were included; 32 (78.0%) died. Median D-dimer and CRP were higher among non-survivors, but biomarker differences did not reach statistical significance. Mechanical ventilation was strongly associated with mortality (96.3% vs 42.9%; p<0.001) and remained significant in an adjusted model (OR 60.20; 95% CI 3.52-1029.34; p=0.005). The clinical model yielded an AUC of 0.712, while adding biomarkers increased AUC to 0.788. Conclusion: In this small ICU cohort, peak thromboinflammatory biomarkers showed directional risk signals but were not statistically significant independent predictors. Requirement for mechanical ventilation was the strongest clinical marker of ICU mortality.

Copyrights © 2026






Journal Info

Abbrev

my-journal

Publisher

Subject

Medicine & Pharmacology

Description

We receive clinical research, experimental research, case reports, and reviews in the scope of all anesthesiology ...